Research Paper Volume 11, Issue 24 pp 12452—12475
Mitochondrial metabolic study guided by proteomics analysis in hepatocellular carcinoma cells surviving long-term incubation with the highest dose of sorafenib
Figure 7. Effect of 2-DG and sorafenib on human HCC cell proliferation. (A, B) HepG2 cells (A) and Huh7 cells (B) were treated for 72 h with 2-DG alone, sorafenib alone, or in combination. Results are presented as the mean ± SD, n=4; *p < 0.05, **p < 0.01 using one-way ANOVA followed by Dunnett′s test.